Skip to Content

Alpha 1-proteinase inhibitor Pregnancy and Breastfeeding Warnings

Alpha 1-proteinase inhibitor is also known as: Aralast, Aralast NP, Glassia, Prolastin, Prolastin-C, Zemaira

Medically reviewed on June 6, 2018

Alpha 1-proteinase inhibitor Pregnancy Warnings

Alpha 1-proteinase inhibitor has been assigned to FDA pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Alpha 1-proteinase inhibitor is only recommended for use during pregnancy when benefit outweighs risk.

See references

Alpha 1-proteinase inhibitor Breastfeeding Warnings

There are no data on the excretion of alpha 1-proteinase inhibitor into human milk. The manufacturer recommends that caution be used when administering alpha 1-proteinase inhibitor to nursing women.

See references

References for pregnancy information

  1. "Product Information. Aralast (alpha 1-proteinase inhibitor)." Baxter I.V. Systems Division, Round Lake, IL.

References for breastfeeding information

  1. "Product Information. Aralast (alpha 1-proteinase inhibitor)." Baxter I.V. Systems Division, Round Lake, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide